Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

Weinstein, Milton C.·1996·JAMA: The Journal of the American Medical Association

Cited by (1,004)

Items 301–400 of 1,004

  1. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
    Dongfeng Gu, Jiang He, Pamela G. Coxson, Petra W. Rasmussen, Chen Huang, Anusorn Thanataveerat, Keane Y. Tzong, Juyang Xiong, Miao Wang, Dong Hui Zhao et al. · 2015 · PLoS Medicine
  2. Preoperative Localization Strategies for Primary Hyperparathyroidism: An Economic Analysis
    Carrie Cunningham Lubitz, Antonia E. Stephen, Richard A. Hodin, Pari V. Pandharipande · 2012 · Annals of Surgical Oncology
  3. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison
    Christian Eugen Mueller, Kirsten Laule-Kilian, A Scholer, Charly Nusbaumer, Thomas Zeller, Daniel Staub, Andra P. Perruchoud · 2004 · Kidney International
  4. Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine
    David Meltzer, Magnus Johannesson · 1999 · Medical Decision Making
  5. Cost-Effectiveness Analysis of Early Reconstruction Versus Rehabilitation and Delayed Reconstruction for Anterior Cruciate Ligament Tears
    Richard C. “Chad” Mather, Carolyn M. Hettrich, Warren Reid Dunn, Brian J. Cole, Bernard Raymond Bach, Laura J. Huston, Emily K. Reinke, Kurt P. Spindler, Lane Koenig, Annunziato Amendola et al. · 2014 · The American Journal of Sports Medicine
  6. The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States
    Maunank Shah, Kathryn Risher, Stephen A. Berry, David W. Dowdy · 2015 · Clinical Infectious Diseases
  7. Treatment Options for Diabetic Neuropathic Foot Ulcers: A Cost-Effectiveness Analysis
    Jonathan Kantor, David J. Margolis · 2001 · Dermatologic Surgery
  8. Minor Head Injury: CT-based Strategies for Management—A Cost-effectiveness Analysis
    Marion Smits, Diederik W.J. Dippel, Paul J. Nederkoorn, Helena Maria Dekker, Pieter E. Vos, Digna R. Kool, Daphne A. van Rijssel, Paul A.M. Hofman, Albert Twijnstra, Herve L. J. Tanghe et al. · 2010 · Radiology
  9. Survival and cost‐effectiveness of sorafenib therapy in advanced hepatocellular carcinoma
    Neehar D. Parikh, Vincent D. Marshall, Amit G. Singal, Hari Nathan, Anna Suk-Fong Lok, Rajesh Balkrishnan, Vahakn B. Shahinian · 2016 · Hepatology
  10. Challenges in measuring and valuing productivity costs, and their relevance in mood disorders
    Benedikte R Lensberg, Drummond, Danchenko, Nicolas Despiégel, Clément François · 2013 · ClinicoEconomics and Outcomes Research
  11. Hypofractionated breast radiotherapy: Financial and economic consequences
    Yolande N. Lievens · 2010 · The Breast
  12. Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?
    Ya‐Chen Tina Shih, Michael T. Halpern · 2008 · CA A Cancer Journal for Clinicians
  13. What outcomes matter to patients?
    Cathy Donald Sherbourne, Roland Sturm, Kenneth Brooks Wells · 1999 · Journal of General Internal Medicine
  14. Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds
    Emran S. Sheikh, Ednan Sheikh, Donald E. Fetterolf · 2013 · International Wound Journal
  15. The impact of hormone replacement therapy on quality of life and willingness to pay
    Niklas Zethraeus, Magnus Johannesson, Peter Henriksson, Roland T. Strand · 1997 · BJOG An International Journal of Obstetrics & Gynaecology
  16. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?
    Claire Bombardier, Andreas Maetzel · 1999 · Annals of the Rheumatic Diseases
  17. Cost‐effectiveness of biologic response modifiers compared to disease‐modifying antirheumatic drugs for rheumatoid arthritis: A systematic review
    Gabrielle van der Velde, Ba’ Pham, Márcio Machado, Luciano Ieraci, William Witteman, Claire Bombardier, Murray Dale Krahn · 2010 · Arthritis Care & Research
  18. Accountable Interventional Pain Management: A Collaboration Among Practitioners, Patients, Payers, and Government
    Laxmaiah Manchikanti · 2013 · Pain Physician
  19. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss
    Neal R. Barshes, James D. Chambers, Joshua T. Cohen, Michael Belkin · 2012 · Journal of Vascular Surgery
  20. Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program
    Ronald T. Ackermann, Sharon L. Edelstein, K.M. Venkat Narayan, Ping Zhang, Michael Maurice Engelgau, William H. Herman, David G. Marrero · 2009 · Obesity
  21. Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost–Benefit Analysis
    Westyn Branch‐Elliman, Sharon B. Wright, Michael D. Howell · 2015 · American Journal of Respiratory and Critical Care Medicine
  22. Cost‐Effectiveness of LDL ‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
    Shravanthi R. Gandra, Guillermo Villa, Gregg C. Fonarow, Mickael Löthgren, Peter Lindgren, Ransi M. Somaratne, Ben van Hout · 2016 · Clinical Cardiology
  23. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
    Reinier G.S. Meester, Ann Graham Zauber, Chyke A. Doubeni, Christopher D. Jensen, Virginia P. Quinn, Mark Helfand, Jason A. Dominitz, Theodore R. Levin, Douglas A. Corley, Iris Lansdorp‐Vogelaar · 2016 · Clinical Gastroenterology and Hepatology
  24. Variations in cost calculations in spine surgery cost-effectiveness research
    Matthew D. Alvin, Jacob A. Miller, Daniel Lubelski, Benjamin P. Rosenbaum, Kalil G. Abdullah, Robert G. Whitmore, Edward C. Benzel, Thomas E. Mroz · 2014 · Neurosurgical FOCUS
  25. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
    Andrew John Palmer, W. J. Valentine, R. Chen, Nazanin Mehin, Sylvie Gabriel, B. Bregman, Roger A. Rodby · 2007 · Nephrology Dialysis Transplantation
  26. Estimating the SF-6D Value Set for a Population-Based Sample of Brazilians
    Luciane Nascimento Cruz, Suzi Alves Camey, Juliana Feliciati Hoffmann, Donna Rowen, John Edward Brazier, Marcelo P. Fleck, Carísi Anne Polanczyk · 2011 · Value in Health
  27. An Economic Analysis of Hand Transplantation in the United States
    Kevin C. Chung, Oda T, Daniel Saddawi‐Konefka, Melissa J. Shauver · 2010 · Plastic & Reconstructive Surgery
  28. Biomarkers in Lung Cancer
    Catherine R. Sears, Peter J. Mazzone · 2020 · Clinics in Chest Medicine
  29. Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
    George Goshua, Pranay Sinha, Jeanne E. Hendrickson, Christopher A. Tormey, Pavan K. Bendapudi, Alfred Ian Lee · 2020 · Blood
  30. Cost-effectiveness analysis: comparing single-level cervical disc replacement and single-level anterior cervical discectomy and fusion
    Sheeraz A. Qureshi, Steven J. McAnany, Vadim Goz, Steven M. Koehler, Andrew C. Hecht · 2013 · Journal of Neurosurgery Spine
  31. Choice of modelling technique for evaluating health care interventions
    Keith Cooper, Sally Brailsford, Richard John Davies · 2006 · Journal of the Operational Research Society
  32. Preference-based quality-of-life in patients with Parkinson’s disease
    Andrew D. Siderowf, Bernard M. Ravina, Henry A. Glick · 2002 · Neurology
  33. Quality-of-Life, Health Service Use, and Costs Associated With Syncope
    Benjamin Sun · 2013 · Progress in Cardiovascular Diseases
  34. The Cost-Effectiveness of Personalized Genetic Medicine
    Siri Atma W. Greeley, Priya M. John, Aaron N. Winn, Joseph Ornelas, Rebecca B. Lipton, Louis H. Philipson, Graeme I. Bell, Elbert S. Huang · 2011 · Diabetes Care
  35. Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee.
    Joanne L. Lord, Christina Rita Victor, Littlejohns, Ross, Axford · 1999 · Health Technology Assessment
  36. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease
    Erickson, Kevin F., Japa, Sohan, Owens, Douglas K., Chertow, Glenn M., Garber, Alan M., Goldhaber-Fiebert, Jeremy D. · 2013 · Journal of the American College of Cardiology
  37. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
    William F. McGhan, Maiwenn Al, Jalpa A. Doshi, Isao Kamae, Steven E. Marx, Donna Rindress · 2009 · Value in Health
  38. Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
    William J. Canestaro, Amanda R. Patrick, Jerry Avorn, Kouta Ito, Olga S. Matlin, Troyen A. Brennan, William H. Shrank, Niteesh K. Choudhry · 2013 · Circulation Cardiovascular Quality and Outcomes
  39. Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma
    Neehar D. Parikh, Amit G. Singal, David W. Hutton · 2017 · Cancer
  40. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China
    Ruyi Xia, Hongmei Zeng, Wenjun Liu, Li Xie, Mingwang Shen, Peng Li, He Li, Wenqiang Wei, Wanqing Chen, Guihua Zhuang · 2021 · JAMA Network Open
  41. Radiofrequency Ablation versus Nephron-sparing Surgery for Small Unilateral Renal Cell Carcinoma: Cost-effectiveness Analysis
    Pari V. Pandharipande, Debra A. Gervais, Peter R. Müeller, Chin Hur, G. Scott Gazelle · 2008 · Radiology
  42. Evidence-based ethics and the care and outcome of extremely premature infants
    Jon E. Tyson, Barbara J. Stoll · 2003 · Clinics in Perinatology
  43. Impact of Ventilator-Associated Pneumonia on Resource Utilization and Patient Outcome
    Stéphane Hugonnet, Philippe Eggimann, FRANÇOIS BORST, Patrice Maricot, Jean-Claude Chevrolet, Didier Pittet · 2004 · Infection Control and Hospital Epidemiology
  44. A Value-Based Medicine Analysis of Ranibizumab for the Treatment of Subfoveal Neovascular Macular Degeneration
    Melissa M. Brown, Gary C. Brown, Heidi C. Brown, Jonathan Peet · 2007 · Ophthalmology
  45. Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies
    G. Scott Gazelle, Pamela M. McMahon, Uwe Siebert, Molly T. Beinfeld · 2005 · Radiology
  46. An Economic Analysis of the Universal Varicella Vaccination Program in the United States
    Fangjun Zhou, Ismael R. Ortega‐Sanchez, Dalya Güriş, Abigail M. Shefer, Tracy A. Lieu, Jane F. Seward · 2008 · The Journal of Infectious Diseases
  47. ECONOMIC EVALUATION IN ORTHOPAEDICS
    Kevin John Bozic, Aaron Glen Rosenberg, Robert S. Huckman, James H. Herndon · 2003 · Journal of Bone and Joint Surgery
  48. Economic Evaluation of Treatment Options in Patients with Alzheimerʼs Disease
    Laura Pouryamout, Judith Dams, Jürgen Wasem, Richard C. Dodel, Anja Neumann · 2012 · Drugs
  49. The cost‐effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model
    Brian Custer, Maria Agapova, Rebecca Havlir Martinez · 2010 · Transfusion
  50. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales
    W. John Edmunds, Marc Brisson, Alessia Melegaro, Nigel J Gay · 2002 · Vaccine
  51. Cost-effectiveness of Interferon-γ Release Assay Screening for Latent Tuberculosis Infection Treatment in Germany
    Roland Diel, Albert Nienhaus, Robert Loddenkemper · 2007 · CHEST Journal
  52. When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
    Roy H. Perlis, Amanda R. Patrick, Jordan W. Smoller, Philip S. Wang · 2009 · Neuropsychopharmacology
  53. An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes
    Ronald T. Ackermann, David G. Marrero, Katherine A. Hicks, Thomas J. Hoerger, Stephen W. Sorensen, Ping Zhang, Michael Maurice Engelgau, Robert E. Ratner, William H. Herman · 2006 · Diabetes Care
  54. Definitions and methods of cost assessment: an intensivist's guide
    Marc Jegers, D. L. Edbrooke, Clare L. Hibbert, Donald B. Chalfin, H. Burchardi · 2002 · Intensive Care Medicine
  55. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden
    Hanly, Paul A, Sharp, Linda · 2014 · BMC Cancer
  56. Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies
    Uri Ladabaum, John Allen, Michael Wandell, Scott Ramsey · 2013 · Cancer Epidemiology Biomarkers & Prevention
  57. Autism spectrum disorders: a review of measures for clinical, health services and cost–effectiveness applications
    Nalin Payakachat, John Mick Tilford, Erica A. Kovacs, Karen A. Kuhlthau · 2012 · Expert Review of Pharmacoeconomics & Outcomes Research
  58. Cost-effectiveness of external cephalic version for term breech presentation
    Jonathan M. Tan, Alex Macario, Brendan Carvalho, Maurice L. Druzin, Yasser Yehia El-Sayed · 2010 · BMC Pregnancy and Childbirth
  59. Economic analysis of complementary medicine: a systematic review
    Adrian R White, E Ernst · 2000 · Complementary Therapies in Medicine
  60. Cost-Effectiveness of Endovascular Stroke Therapy
    Wolfgang Gerhard Kunz, M. G. Myriam Hunink, Wieland H. Sommer, Sebastian E. Beyer, Felix G. Meinel, Franziska Dorn, Stefan Wirth, Maximilian Ferdinand Reiser, Birgit Betina Ertl-Wagner, Kolja M. Thierfelder · 2016 · Stroke
  61. The Cost-Effectiveness of Treatment Strategies for Achalasia
    John B. O’Connor, Mendel E. Singer, Thomas F. Imperiale, Michael Fredrick Vaezi, Joel E. Richter · 2002 · Digestive Diseases and Sciences
  62. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units
    Christianne A. van Nieuwenhoven, Erik Buskens, Dennis C. J. J. Bergmans, Frank H. van Tiel, Graham Ramsay, Marc J. M. Bonten · 2004 · Critical Care Medicine
  63. Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
    Anthony O’Hagan, John Stevens, Jacques Montmartin · 2000 · PharmacoEconomics
  64. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors
    Helen P. Kourea, Mark H. Bilsky, Denis H. Y. Leung, Jonathan J. Lewis, James M. Woodruff · 1998 · Cancer
  65. Enhancing Mammography Use in the Inner City
    Barbara E. Weber · 1997 · Archives of Internal Medicine
  66. Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma
    Xin Zhang, Jingjing Wang, Juanjuan Shi, Xiaoli Jia, Shuangsuo Dang, Wenjun Wang · 2021 · JAMA Network Open
  67. Cost-Utility Analysis Studies of Depression Management: A Systematic Review
    Paul A. Pirraglia, Allison B. Rosen, Richard C. Hermann, Natalia Olchanski, Peter J. Neumann · 2004 · American Journal of Psychiatry
  68. Cost-Effectiveness of Sacubitril–Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
    Alexander T. Sandhu, Daniel A. Ollendorf, Richard H. Chapman, Steven D. Pearson, Paul A. Heidenreich · 2016 · Annals of Internal Medicine
  69. Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen
    Kyle A. Beauchamp, Katherine Johansen Taber, Dale Muzzey · 2019 · Genetics in Medicine
  70. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results
    George W. Torrance, Jean‐Pierre Raynauld, Valery Walker, Charlie H. Goldsmith, Nicholas Bellamy, Philip A. Band, M. Schultz, Peter Tugwell · 2002 · Osteoarthritis and Cartilage
  71. Assessment of health economics in Alzheimer’s disease (AHEAD)
    Denis Getsios, J. Jaime, G. Caro, K Ishak, for the AHEAD Study Group · 2001 · Neurology
  72. Breast cancer screening among women younger than age 50: a current assessment of the issues
    R. A. Smith · 2000 · CA A Cancer Journal for Clinicians
  73. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study
    Jochen M. Schmitt, M. Meurer, M. Klon, Kevin D. Frick · 2007 · British Journal of Dermatology
  74. EQ-5D for the Assessment of Health-Related Quality of Life and Resource Allocation in Children: A Systematic Methodological Review
    Jane Noyes, Rhiannon Tudor Edwards · 2011 · Value in Health
  75. Cost-Effectiveness of Contralateral Prophylactic Mastectomy Versus Routine Surveillance in Patients With Unilateral Breast Cancer
    Benjamin Zendejas, James P. Moriarty, Jamie J. O’Byrne, Amy C. Degnim, David R. Farley, Judy Caroline Boughey · 2011 · Journal of Clinical Oncology
  76. Reducing Hospital Expenditures With the COPE (Creating Opportunities for Parent Empowerment) Program for Parents and Premature Infants
    Bernadette Mazurek Melnyk, Nancy Fischbeck Feinstein · 2009 · Nursing Administration Quarterly
  77. Cost-Effectiveness of Photodynamic Therapy for Treatment of Barrett's Esophagus with High Grade Dysplasia
    Chin Hur, Norman S. Nishioka, G. Scott Gazelle · 2003 · Digestive Diseases and Sciences
  78. Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction
    Gillian D Sanders, Mark Andrew Hlatky, Nathan R. Every, Kathryn Mack McDonald, Paul A. Heidenreich, Lori S. Parsons, Douglas K Owens · 2001 · Annals of Internal Medicine
  79. Barriers to Office-Based Screening Sigmoidoscopy: Does Reimbursement Cover Costs?
    James D. Lewis, David A. Asch · 1999 · Annals of Internal Medicine
  80. Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin*
    Andrew F. Shorr, Gregory M. Susla, Marin H. Kollef · 2004 · Critical Care Medicine
  81. Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis
    Karine Sejean, Sophie Calmus, Isabelle Durand‐Zaleski, Philippe Bonnichon, Pierre THOMOPOULOS, Catherine Cormier, Paul Legmann, Bruno Richard, XAVIER Y. BERTAGNA, Gwenaëlle M. Vidal-Trecan · 2005 · European Journal of Endocrinology
  82. Robot-assisted unicompartmental knee arthroplasty for patients with isolated medial compartment osteoarthritis is cost-effective
    Nick D. Clement, David John Deehan, James T. Patton · 2019 · The Bone & Joint Journal
  83. Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers
    Lisa Saldana, Debra Pearson Ritzwoller, Mark Robin Campbell, Eryn Piper Block · 2022 · Implementation Science Communications
  84. Cost, Effectiveness, and Cost-Effectiveness
    George A. Diamond, Sanjay Kaul · 2009 · Circulation Cardiovascular Quality and Outcomes
  85. Health Outcomes and Costs of Community Mitigation Strategies for an Influenza Pandemic in the United States
    Daniella J. Perlroth, Robert J. Glass, Victoria J. Davey, Daniel C. Cannon, Alan M. Garber, Douglas K Owens · 2009 · Clinical Infectious Diseases
  86. Cost-Effectiveness Analysis in Radiology
    Mendel E. Singer, Kimberly E. Applegate · 2001 · Radiology
  87. Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain
    Leslee J. Shaw, Thomas Hugh Marwick, Daniel S. Berman, Stephen G. Sawada, G.V. Heller, Charles G. Vasey, D. Douglas Miller · 2006 · European Heart Journal
  88. Comparison of endovascular and open surgical repairs for abdominal aortic aneurysm.
    Timothy J Wilt, Frank A. Lederle, Roderick H. MacDonald, Yvonne Catharina Jonk, Thomas S. Rector, Robert L Kane · 2006 · PubMed Central
  89. Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?
    Andreas Laupacis · 2002 · PubMed Central
  90. Cost-effectiveness analysis and incremental cost-effectiveness ratios
    Kiran M. Bambha, W. Ray Kim · 2004 · European Journal of Gastroenterology & Hepatology
  91. The Optimal Imaging Strategy for Patients With Stable Chest Pain
    Tessa S.S. Genders, Steffen Erhard Petersen, Francesca Pugliese, Amardeep Ghosh Dastidar, Kirsten E. Fleischmann, Koen Nieman, M. G. Myriam Hunink · 2015 · Annals of Internal Medicine
  92. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis
    Gauree Gupta Konijeti, Mark G. Shrime, Ashwin N. Ananthakrishnan, Andrew Tan Chan · 2013 · Gastrointestinal Endoscopy
  93. Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment
    P. Muntner, P. Whelton · 2017 · Journal of the American College of Cardiology
  94. To Supplement or Not to Supplement: A Cost-Utility Analysis of Calcium and Vitamin D Repletion in Patients After Thyroidectomy
    Tracy S. Wang, Kevin Cheung, Sanziana A. Roman, Julie Ann Sosa · 2010 · Annals of Surgical Oncology
  95. Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study
    S. Grandy, K. Fox · 2012 · Health and Quality of Life Outcomes
  96. Measuring the Health of Populations: Explaining Composite Indicators
    Adnan Ali Hyder, Prasanthi Puvanachandra, Richard H. Morrow · 2012 · Journal of Public Health Research
  97. The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model
    Brian Barlow, Alexander S. McLawhorn, Geoffrey H. Westrich · 2017 · Journal of Bone and Joint Surgery
  98. Cost-efficacy of Knee Cartilage Defect Treatments in the United States
    Joshua Scott Everhart, Andrew B. Campbell, Moneer M. Abouljoud, James Caid Kirven, David C. Flanigan · 2019 · The American Journal of Sports Medicine
  99. Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis
    Monia Marchetti, Angela Pistorio, Marisa Barone, Silvia Serafini, Giovanni Barosi · 2001 · The American Journal of Medicine
  100. Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model
    HH König · 2004 · British Journal of Ophthalmology